Cyclerion Therapeutics Inc Asset Turnover Ratio (CYCN), as of second quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Cyclerion Therapeutics Inc   (NASDAQ: CYCN)
 

Cyclerion Therapeutics Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

According to the latest Balance sheet Jun 30 2026, Cyclerion Therapeutics Inc has not recorded any assets.
Visit Cyclerion Therapeutics Inc Balance sheet

Within sector Cyclerion Therapeutics Inc achieved the highest asset turnover ratio. While asset turnover ranking remained unchanged in the Second Quarter 2026 compared to previous quarter at no. .

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CYCN Asset Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Asset Change -26.16 % -13.63 % -33.1 % -26.9 % -15.32 %
Y / Y Revenue Change - - -43.24 % 351.03 % -
Asset Turnover Ratio (TTM) - - 0.21 0.26 0.18
CYCN's Total Ranking # # # # #
Seq. Asset Change -18.65 % -14.82 % -4.13 % 11.15 % -4.84 %
Seq. Revenue Change - - 17.14 % 840.86 % 14.81 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0 0 0
 




CYCN Company Profile • Back to CYCN Efficiency Comparisons • Compare CYCN Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Assets at quarter ending Jun 30 2026
Harmony Biosciences Holdings inc   0.75 $ 960.191  Millions$ 1,281.189  Millions
Sight Sciences Inc   0.75 $ 83.351  Millions$ 111.533  Millions
Novocure Limited  0.75 $ 699.193  Millions$ 937.159  Millions
Verrica Pharmaceuticals Inc   0.74 $ 30.321  Millions$ 40.707  Millions
Staar Surgical Co  0.74 $ 339.590  Millions$ 458.591  Millions
Adapthealth Corp   0.74 $ 3,226.709  Millions$ 4,366.244  Millions
Dexcom Inc   0.74 $ 4,968.800  Millions$ 6,732.125  Millions
Delcath Systems Inc   0.74 $ 94.058  Millions$ 127.446  Millions
Journey Medical Corp  0.74 $ 68.181  Millions$ 92.417  Millions
Beone Medicines Ltd   0.73 $ 6,128.238  Millions$ 8,387.598  Millions
Lifestance Health Group Inc   0.73 $ 1,584.834  Millions$ 2,170.070  Millions
Acadia Pharmaceuticals Inc   0.73 $ 1,138.643  Millions$ 1,560.774  Millions
Biomerica Inc   0.73 $ 4.453  Millions$ 6.109  Millions
Tenet Healthcare Corp  0.72 $ 21,812.000  Millions$ 30,243.500  Millions
Neurocrine Biosciences Inc   0.70 $ 3,373.900  Millions$ 4,790.625  Millions
Establishment Labs Holdings Inc   0.70 $ 245.105  Millions$ 349.756  Millions
Quest Diagnostics Inc  0.70 $ 11,560.000  Millions$ 16,508.500  Millions
Jaguar Health Inc   0.70 $ 27.815  Millions$ 39.856  Millions
Pulmonx Corporation  0.70 $ 87.393  Millions$ 125.568  Millions
Mirum Pharmaceuticals Inc   0.69 $ 618.067  Millions$ 890.956  Millions
3m Company  0.69 $ 25,180.000  Millions$ 36,426.000  Millions
Illumina Inc   0.69 $ 4,493.000  Millions$ 6,507.500  Millions
Neuraxis Inc   0.69 $ 5.316  Millions$ 7.731  Millions
Harrow Inc   0.69 $ 274.724  Millions$ 399.729  Millions
Ani Pharmaceuticals Inc  0.68 $ 978.379  Millions$ 1,441.153  Millions
Procept Biorobotics Corporation  0.68 $ 336.764  Millions$ 496.509  Millions
Dentsply Sirona Inc   0.68 $ 3,643.000  Millions$ 5,378.750  Millions
Lantheus Holdings Inc   0.67 $ 1,555.343  Millions$ 2,316.262  Millions
Halozyme Therapeutics Inc   0.67 $ 1,663.738  Millions$ 2,499.171  Millions
Immucell Corporation  0.67 $ 29.777  Millions$ 44.750  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.